Paul Major, fund manager, BB Healthcare Trust shares his thoughts on the rollout of vaccines in the UK and what new data is telling us about the future of COVID-19. Please explain the efficacy of the UK’s dosing approach: prioritising the maximisation of first doses administered and thus delaying the second dose of the Pfizer […]
Optimum supports Anglonordic, the only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other.
European innovators helped pave the way for the world’s first COVID-19 vaccines. What’s coming next from Europe’s academic and biotech leaders?
To be credible and investible, ESG is becoming critical to the fund manager’s perspective, as investors shift further to sustainable investment.
February is Heart Awareness Month. In this Insight, Karin Kleinhans of LSP discusses how heart failure, one of the leading causes of death worldwide, is a global problem that demands urgent attention.
